Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Pulse Biosciences CS (PLSE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 322,662
  • Shares Outstanding, K 20,710
  • Annual Sales, $ 0 K
  • Annual Income, $ -37,550 K
  • 60-Month Beta 1.67
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 4.83

Price Performance

See More
Period Period Low Period High Performance
1-Month
15.11 +3.14%
on 04/17/19
19.77 -21.19%
on 03/21/19
-2.67 (-14.63%)
since 03/18/19
3-Month
11.50 +35.48%
on 01/22/19
19.77 -21.19%
on 03/21/19
+3.34 (+27.29%)
since 01/18/19
52-Week
8.60 +81.16%
on 10/23/18
22.20 -29.82%
on 05/08/18
-3.99 (-20.39%)
since 04/18/18

Most Recent Stories

More News
Pulse Biosciences to Report First Quarter 2019 Operational Highlights and Financial Results

Pulse Biosciences, Inc. (NASDAQ:PLSE), a novel medical therapy company bringing to market its proprietary CellFX(TM) System today announced that the Company will report first quarter 2019...

PLSE : 15.58 (+0.13%)
Pulse Biosciences Grants Equity Incentive Awards to New Employees

Pulse Biosciences, Inc. (Nasdaq: PLSE) ("Pulse Biosciences" or the "Company"), a novel medical therapy company bringing to market its proprietary CellFX(TM) System, announced today that the...

PLSE : 15.58 (+0.13%)
Market Trends Toward New Normal in BlackBerry, Axsome Therapeutics, Pulse Biosciences, Whitestone REIT, Anworth Mortgage Asset, and Synchronoss Technologies -- Emerging Consolidated Expectations, Analyst Ratings

In new independent research reports released early this morning, Capital Review released its latest key findings for all current investors, traders, and shareholders of BlackBerry Limited (NYSE:BB), Axsome...

BB : 9.21 (unch)
WSR : 12.25 (+0.91%)
PLSE : 15.58 (+0.13%)
ANH : 4.10 (unch)
SNCR : 5.44 (-3.55%)
AXSM : 15.01 (+0.74%)
Pulse Biosciences Announces Presentations at the 2019 American Society for Laser Medicine and Surgery Annual Conference

Pulse Biosciences, Inc. (NASDAQ:PLSE), a novel medical therapy company bringing to market its proprietary CellFX(TM) System, today announced that key findings from its clinical programs using...

PLSE : 15.58 (+0.13%)
Pulse Biosciences Appoints Mitchell Levinson to Board of Directors

Pulse Biosciences, Inc.(NASDAQ:PLSE) ("Pulse Biosciences" or the "Company"), a novel medical therapy company bringing to market its proprietary CellFX(TM) System, today announced the appointment...

PLSE : 15.58 (+0.13%)
Pulse Biosciences Grants Equity Incentive Awards to New Employees

Pulse Biosciences, Inc. (Nasdaq: PLSE) ("Pulse Biosciences" or the "Company"), a novel medical therapy company bringing to market its proprietary CellFX(TM) System, announced today that the...

PLSE : 15.58 (+0.13%)
Pulse Biosciences Announces Late Breaking Oral Presentation of Sebaceous Hyperplasia Study Results at the 2019 AAD Annual Meeting

Pulse Biosciences, Inc. (NASDAQ:PLSE), a novel medical therapy company bringing to market its proprietary CellFX(TM) System, today announced that clinical results from its recently completed...

PLSE : 15.58 (+0.13%)
Pulse Biosciences Submits 510(K) to U.S. FDA for CellFX(TM) System

Pulse Biosciences, Inc. (NASDAQ:PLSE), a novel medical therapy company bringing to market its proprietary CellFX(TM) System today announced the Premarket Notification 510(k) submission to...

PLSE : 15.58 (+0.13%)
Pulse Biosciences Grants Equity Incentive Awards to New Employees

Pulse Biosciences, Inc. (Nasdaq: PLSE) ("Pulse Biosciences" or the "Company"), a novel medical therapy company bringing to market its proprietary CellFX(TM) System, announced today that the...

PLSE : 15.58 (+0.13%)
Ascentage Pharma Appoints Jeff Kmetz as Chief Business Officer

Ascentage Pharma, a global clinical-stage biopharmaceutical company dedicated to developing apoptosis-targeted therapies for cancers and other diseases, today announced the appointment of Jeff Kmetz as...

PLSE : 15.58 (+0.13%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Trade PLSE with:

Business Summary

Pulse Biosciences, Inc. is a medical device company. It is engaged in developing a novel and proprietary tissue treatment platform using Nano-Pulse Electro-Signaling. NPES provide effective local tumor control and to initiate an adaptive immune response. The company deploy NPES platform applications...

See More

Key Turning Points

2nd Resistance Point 16.07
1st Resistance Point 15.83
Last Price 15.58
1st Support Level 15.36
2nd Support Level 15.13

See More

52-Week High 22.20
Fibonacci 61.8% 17.00
Last Price 15.58
Fibonacci 50% 15.40
Fibonacci 38.2% 13.80
52-Week Low 8.60

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar